Ibuprofen or Non-Steroidal Anti-inflammatory (NSAIDs) Medications

COVID-19 Vaccine

A vaccine involves introducing an agent that resembles or includes part of the virus into the body to provoke an immune response to the virus. Currently, there is no vaccine for COVID-19. Vaccines can take years to create, but genetic engineering is being used to help create a vaccine for COVID-19 as quickly as possible.

National Jewish Health scientists and others around the world are working to develop a vaccine.

The U.S. government estimates that a COVID-19 vaccine is about 12-18 months away (from April 2020).

ChAdOx1 nCoV-19 is starting phase 1 of human vaccine trial in the United Kingdom. This vaccine uses a weakened common cold virus to teach the immune system to recognize SARS-CoV-2 and fight the virus. Researchers believe the vaccine will be available by fall.

Recombinant Adenovirus Type-5 (Ad5) concluded phase 1 trials with the vaccine showing the ability to help participants develop antibodies to SARS-CoV-2 with mild-to-moderate adverse effects. The research team is recruiting for phase 2 of the trial.

Here is a list of clinical trials are underway in the U.S. and other countries.